These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome. Geczy C, Raper R, Roberts IM, Meyer P, Bernard CC. J Neuroimmunol; 1985 Aug; 9(3-4):179-91. PubMed ID: 2410449 [Abstract] [Full Text] [Related]
29. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome. Yuki N, Yamada M, Sato S, Ohama E, Kawase Y, Ikuta F, Miyatake T. Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262 [Abstract] [Full Text] [Related]
30. Passive transfer studies in Guillain-Barré polyneuropathy. Feasby TE, Hahn AF, Gilbert JJ. Neurology; 1982 Oct; 32(10):1159-67. PubMed ID: 6889701 [Abstract] [Full Text] [Related]
31. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Ann Neurol; 1996 May; 39(5):625-35. PubMed ID: 8619548 [Abstract] [Full Text] [Related]
33. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis]. Shimoya K, Ohnishi A, Hashimoto T, Yuki N. Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140 [Abstract] [Full Text] [Related]
37. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Enders U, Karch H, Toyka KV, Michels M, Zielasek J, Pette M, Heesemann J, Hartung HP. Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338 [Abstract] [Full Text] [Related]